3 most recent filings and news items mentioning BJDX. Updated every 60 seconds.
RegulatoryJun 9, 2026Neutral
The company's Board approved Amendment No. 1 to its 2021 Stock Plan on April 28, 2026, with stockholder approval on June 9, 2026. The amendment modifies the equity compensation framework for key employees, directors, and consultants.
View filing at SEC.gov →
OfferingJun 8, 2026Neutral
Bluejay Diagnostics filed a pre-funded common stock purchase warrant form exercisable for shares at a future price. The unregistered securities offering allows existing investors to purchase common stock at minimal upfront cost under terms outlined in a June 2, 2026 purchase agre
View filing at SEC.gov →
OtherJun 2, 2026Positive
Bluejay Diagnostics entered into a manufacturing agreement with Argonaut Manufacturing Services for reservoir fill and seal production, effective May 27, 2026. The partnership includes technology transfer, quality management, validation services, and supply chain support for diag
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.